• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痘苗病毒安卡拉株宿主范围限制缺陷的标志物拯救

Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.

作者信息

Wyatt L S, Carroll M W, Czerny C P, Merchlinsky M, Sisler J R, Moss B

机构信息

National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA.

出版信息

Virology. 1998 Nov 25;251(2):334-42. doi: 10.1006/viro.1998.9397.

DOI:10.1006/viro.1998.9397
PMID:9837798
Abstract

The severely attenuated and host range (HR) restricted modified vaccinia virus Ankara (MVA) was derived by >500 passages in chick embryo fibroblasts, during which multiple deletions and mutations occurred. To determine the basis of the HR defect, we prepared cosmids from the parental vaccinia virus Ankara genome and transfected them into nonpermissive monkey BS-C-1 cells that had been infected with MVA. Recombinant viruses that formed macroscopic plaques were detected after transfections with DNA segments that mapped near the left end of the viral genome. Plaque-forming viruses, generated by transfections with four individual cosmids and one pair of minimally overlapping cosmids, were purified, and their HRs were evaluated in BS-C-1 cells, rabbit RK-13 cells, and human HeLa, MRC-5, and A549 cells. The acquisition of the K1L and SPI-1 HR genes and the repair of large deletions were determined by polymerase chain reaction or pulse-field gel electrophoresis of NotI restriction enzyme digests of genomic DNA. The following results indicated the presence of previously unrecognized vaccinia virus HR genes: (1) the major mutations that restrict HR are within the left end of the MVA genome because the phenotypes of some recombinants approached that of the parental virus, (2) acquisition of the K1L gene correlated with the ability of recombinant viruses to propagate in RK-13 cells but did not enhance replication in human or monkey cell lines, (3) acquisition of the SPI-1 gene correlated with virus propagation in A549 cells but not with the extent of virus spread in monkey or other human cell lines, (4) there are at least two impaired HR genes because rescue occurred with nonoverlapping or minimally overlapping cosmids and recombinant viruses with intermediate HRs were isolated, and (5) at least one of the new HR genes did not map within any of the major deletions because the size of the left terminal NotI fragment was not appreciably altered in some recombinant viruses.

摘要

严重减毒且宿主范围(HR)受限的改良痘苗病毒安卡拉株(MVA)是通过在鸡胚成纤维细胞中传代500多次获得的,在此过程中发生了多个缺失和突变。为了确定HR缺陷的基础,我们从亲本痘苗病毒安卡拉基因组制备了黏粒,并将其转染到已感染MVA的非允许性猴BS-C-1细胞中。在用定位在病毒基因组左端附近的DNA片段转染后,检测到形成宏观噬斑的重组病毒。用四个单独的黏粒和一对最小重叠黏粒转染产生的噬斑形成病毒被纯化,并在BS-C-1细胞、兔RK-13细胞以及人HeLa、MRC-5和A549细胞中评估其HR。通过聚合酶链反应或基因组DNA的NotI限制性酶切消化的脉冲场凝胶电泳来确定K1L和SPI-1 HR基因的获得以及大缺失的修复。以下结果表明存在先前未被认识的痘苗病毒HR基因:(1)限制HR的主要突变位于MVA基因组的左端,因为一些重组体的表型接近亲本病毒,(2)K1L基因的获得与重组病毒在RK-13细胞中的增殖能力相关,但不增强在人或猴细胞系中的复制,(3)SPI-1基因的获得与病毒在A549细胞中的增殖相关,但与病毒在猴或其他人细胞系中的传播程度无关,(4)至少有两个受损的HR基因,因为用非重叠或最小重叠黏粒进行了拯救,并且分离出了具有中等HR的重组病毒,(5)至少有一个新的HR基因不在任何主要缺失范围内,因为在一些重组病毒中左端NotI片段的大小没有明显改变。

相似文献

1
Marker rescue of the host range restriction defects of modified vaccinia virus Ankara.痘苗病毒安卡拉株宿主范围限制缺陷的标志物拯救
Virology. 1998 Nov 25;251(2):334-42. doi: 10.1006/viro.1998.9397.
2
Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.痘苗病毒高度减毒的MVA株的宿主范围和细胞致病性:在非人类哺乳动物细胞系中重组病毒的增殖与产生
Virology. 1997 Nov 24;238(2):198-211. doi: 10.1006/viro.1997.8845.
3
Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.在改良安卡拉痘苗病毒中,功能性 F11L 和 K1L 基因可恢复病毒诱导的细胞运动性,但不能恢复人源和鼠源细胞中的病毒生长。
Virology. 2010 Sep 1;404(2):231-9. doi: 10.1016/j.virol.2010.05.008.
4
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain.实际上,具有相同编码序列的改良安卡拉牛痘病毒株是决定每种病毒株生物学特性的病毒的复杂混合物。
Vaccine. 2009 Dec 9;27(52):7442-50. doi: 10.1016/j.vaccine.2009.05.095. Epub 2009 Jun 17.
5
Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.高度减毒痘苗病毒MVA基因组中缺失区域的定位及其对毒力的影响。
J Gen Virol. 1991 May;72 ( Pt 5):1031-8. doi: 10.1099/0022-1317-72-5-1031.
6
Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.通过非同源CP77基因对痘苗病毒宿主范围K1L基因缺失进行互补。
Virology. 1996 Aug 1;222(1):75-86. doi: 10.1006/viro.1996.0399.
7
Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.去帽酶中的自发和靶向突变增强了猴细胞中 Modified Vaccinia Virus Ankara(MVA)的复制。
J Virol. 2021 Sep 9;95(19):e0110421. doi: 10.1128/JVI.01104-21.
8
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.SPI-1 是一种缺失的宿主范围因子,对于减毒的改良安卡拉牛痘(MVA)疫苗载体在人细胞中的复制是必需的。
PLoS Pathog. 2019 May 30;15(5):e1007710. doi: 10.1371/journal.ppat.1007710. eCollection 2019 May.
9
The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses.改良安卡拉痘苗病毒株的全基因组序列:与其他正痘病毒的比较。
Virology. 1998 May 10;244(2):365-96. doi: 10.1006/viro.1998.9123.
10
Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection.标记基因交换通过宿主范围选择促进重组安卡拉痘苗病毒的生产。
J Virol Methods. 2009 Mar;156(1-2):37-43. doi: 10.1016/j.jviromet.2008.10.026. Epub 2008 Dec 10.

引用本文的文献

1
Molecular evolution of 2022 multi-country outbreak-causing monkeypox virus Clade IIb.2022年多国猴痘疫情致病病毒分支IIb的分子进化
iScience. 2023 Dec 1;27(1):108601. doi: 10.1016/j.isci.2023.108601. eCollection 2024 Jan 19.
2
Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection.定量蛋白质组学定义了在改良安卡拉痘苗病毒感染期间抗病毒防御和细胞死亡的机制。
Nat Commun. 2023 Dec 8;14(1):8134. doi: 10.1038/s41467-023-43299-8.
3
Extracellular Vesicles and Their Use as Vehicles of Immunogens.
细胞外囊泡及其作为免疫原载体的用途。
Methods Mol Biol. 2022;2504:177-198. doi: 10.1007/978-1-0716-2341-1_13.
4
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.痘苗病毒:从粗糙的天花疫苗到精细的病毒载体疫苗设计
Biomedicines. 2021 Nov 26;9(12):1780. doi: 10.3390/biomedicines9121780.
5
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.用作疫苗载体的重组牛结节性皮肤病病毒(LSDV)生长与构建的进展
Vaccines (Basel). 2021 Oct 4;9(10):1131. doi: 10.3390/vaccines9101131.
6
Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.去帽酶中的自发和靶向突变增强了猴细胞中 Modified Vaccinia Virus Ankara(MVA)的复制。
J Virol. 2021 Sep 9;95(19):e0110421. doi: 10.1128/JVI.01104-21.
7
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.锌指抗病毒蛋白(ZAP)是一种限制人细胞中改良安卡拉痘苗病毒(MVA)复制的限制因子。
PLoS Pathog. 2020 Aug 31;16(8):e1008845. doi: 10.1371/journal.ppat.1008845. eCollection 2020 Aug.
8
A vital gene for modified vaccinia virus Ankara replication in human cells.用于改良安卡拉痘苗病毒在人细胞中复制的一个关键基因。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6289-6291. doi: 10.1073/pnas.2001335117. Epub 2020 Mar 16.
9
Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.先前未被描述的第二宿主范围基因的修复有助于改良安卡拉痘苗病毒(MVA)在人细胞中的完全复制。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3759-3767. doi: 10.1073/pnas.1921098117. Epub 2020 Feb 4.
10
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.SPI-1 是一种缺失的宿主范围因子,对于减毒的改良安卡拉牛痘(MVA)疫苗载体在人细胞中的复制是必需的。
PLoS Pathog. 2019 May 30;15(5):e1007710. doi: 10.1371/journal.ppat.1007710. eCollection 2019 May.